DK528980A - Fremgangsmaade til fremstilling af basiske ethere eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf - Google Patents

Fremgangsmaade til fremstilling af basiske ethere eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf

Info

Publication number
DK528980A
DK528980A DK528980A DK528980A DK528980A DK 528980 A DK528980 A DK 528980A DK 528980 A DK528980 A DK 528980A DK 528980 A DK528980 A DK 528980A DK 528980 A DK528980 A DK 528980A
Authority
DK
Denmark
Prior art keywords
salts
procedure
preparation
acceptable acid
pharmaceutical acceptable
Prior art date
Application number
DK528980A
Other languages
English (en)
Other versions
DK156825B (da
DK156825C (da
Inventor
Z Budai
L Magdanyi
A Lay
T Mezel
K Grasser
L Petoecz
I Kosoczky
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DK528980A publication Critical patent/DK528980A/da
Publication of DK156825B publication Critical patent/DK156825B/da
Application granted granted Critical
Publication of DK156825C publication Critical patent/DK156825C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK528980A 1979-12-14 1980-12-11 Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf DK156825C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUEE002715 1979-12-14
HU79EE2715A HU179164B (en) 1979-12-14 1979-12-14 Process for producing cycloalkyl-ethers of alkanolamines

Publications (3)

Publication Number Publication Date
DK528980A true DK528980A (da) 1981-06-15
DK156825B DK156825B (da) 1989-10-09
DK156825C DK156825C (da) 1990-03-12

Family

ID=10995882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528980A DK156825C (da) 1979-12-14 1980-12-11 Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf

Country Status (27)

Country Link
US (1) US4342762A (da)
JP (1) JPS56123953A (da)
AT (1) AT374449B (da)
AU (1) AU539173B2 (da)
BE (1) BE886579A (da)
CA (1) CA1155115A (da)
CH (1) CH649986A5 (da)
CS (1) CS216544B2 (da)
DD (1) DD155320A5 (da)
DE (1) DE3047142C2 (da)
DK (1) DK156825C (da)
ES (1) ES8200857A1 (da)
FI (1) FI76783C (da)
FR (1) FR2471968B1 (da)
GB (1) GB2065122B (da)
GR (1) GR72509B (da)
HU (1) HU179164B (da)
IE (1) IE51733B1 (da)
IL (1) IL61685A (da)
IT (1) IT1209377B (da)
NL (1) NL193907C (da)
NO (1) NO150638C (da)
PL (1) PL127036B1 (da)
SE (1) SE451132B (da)
SU (1) SU1253425A3 (da)
UA (1) UA5566A1 (da)
YU (1) YU42367B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
JPH0626170A (ja) * 1992-07-09 1994-02-01 Yodogawa Steel Works Ltd 壁板材の取付構造
JPH06193226A (ja) * 1992-12-26 1994-07-12 Yodogawa Steel Works Ltd 壁板材の取付構造
US5652270A (en) * 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
KR100381558B1 (ko) * 1994-07-01 2003-08-19 에지스 지오기스제르기아르 알티. 약제조성물및이의제조방법
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
US6335372B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Treatment of obsessive compulsive disorder
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
KR101493508B1 (ko) * 2013-02-18 2015-02-16 오스템임플란트 주식회사 치아 미백 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246462A (da) * 1959-08-06
GB895050A (en) * 1960-01-29 1962-04-26 Boehringer & Soehne Gmbh New basic ethers
DE1108684B (de) * 1960-01-29 1961-06-15 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer basischer AEther
AT264495B (de) * 1963-08-18 1968-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern
GB1085969A (en) * 1965-08-11 1967-10-04 Glidden Co Insectiphobic compositions comprising terpene derivatives
US4118499A (en) * 1975-10-15 1978-10-03 Glaxo Laboratories Limited Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法

Also Published As

Publication number Publication date
ATA601380A (de) 1983-09-15
PL127036B1 (en) 1983-09-30
AU6529380A (en) 1981-06-18
DE3047142C2 (de) 1985-09-26
IE51733B1 (en) 1987-03-18
FR2471968B1 (fr) 1986-08-22
PL228392A1 (da) 1981-08-07
ES497717A0 (es) 1981-11-16
DD155320A5 (de) 1982-06-02
IT1209377B (it) 1989-07-16
YU42367B (en) 1988-08-31
NO150638B (no) 1984-08-13
CS216544B2 (en) 1982-11-26
IL61685A0 (en) 1981-01-30
GB2065122A (en) 1981-06-24
NO150638C (no) 1984-11-21
JPS56123953A (en) 1981-09-29
CA1155115A (en) 1983-10-11
FR2471968A1 (fr) 1981-06-26
FI803858L (fi) 1981-06-15
CH649986A5 (de) 1985-06-28
NO803764L (no) 1981-06-15
YU311180A (en) 1983-10-31
FI76783B (fi) 1988-08-31
DK156825B (da) 1989-10-09
GB2065122B (en) 1983-06-29
FI76783C (fi) 1988-12-12
NL193907B (nl) 2000-10-02
SU1253425A3 (ru) 1986-08-23
ES8200857A1 (es) 1981-11-16
US4342762A (en) 1982-08-03
IT8026587A0 (it) 1980-12-12
HU179164B (en) 1982-08-28
BE886579A (fr) 1981-06-10
DE3047142A1 (de) 1981-09-10
AT374449B (de) 1984-04-25
IE802612L (en) 1981-06-14
SE451132B (sv) 1987-09-07
UA5566A1 (uk) 1994-12-28
AU539173B2 (en) 1984-09-13
DK156825C (da) 1990-03-12
JPS6314703B2 (da) 1988-04-01
NL193907C (nl) 2001-02-05
IL61685A (en) 1984-10-31
SE8008680L (sv) 1981-06-15
NL8006722A (nl) 1981-07-16
GR72509B (da) 1983-11-16

Similar Documents

Publication Publication Date Title
DK528980A (da) Fremgangsmaade til fremstilling af basiske ethere eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK164543C (da) Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK178379A (da) Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf
DK358980A (da) Fremgangsmaade til fremstilling af salte af (+)-katekin
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK70083D0 (da) Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK509780A (da) Fremgangsmaade til fremstilling af anti-tumoraktive salte
DK149479A (da) Fremgangsmaade til fremstilling af betalactamforbindelser eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PUP Patent expired